0
0
0
0
1
2
3
$0
Is Constellation Brands solid or fragile? The Finex Financial Health Scanner reads STZ's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $9.1B |
|---|---|
| Net income | $1.7B |
| Operating margin | 29.8% |
| Net margin | 18.5% |
| Cash and investments | $102.4M |
| Total debt | $10.6B |
| Free cash flow | $1.1B |
| Revenue growth (1 year) | -10.5% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.